SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

about

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

Item

http://www.wikidata.org/entity/Q49900699

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

@en

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

@nl

type

Item

label

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

@en

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

@nl

prefLabel

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

@en

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma.

@nl

P1476

SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma

@en

P2093

Dong Zhou

http://www.w3.org/2001/XMLSchema#string

Ji-Gang Dai

http://www.w3.org/2001/XMLSchema#string

Qian Chen

http://www.w3.org/2001/XMLSchema#string

Quan-Xing Liu

http://www.w3.org/2001/XMLSchema#string

Xiao Lu

http://www.w3.org/2001/XMLSchema#string

Yuan Qiu

http://www.w3.org/2001/XMLSchema#string

P2860

SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis.

Differential activation and function of Rho GTPases during Salmonella-host cell interactions

Global cancer statistics, 2012

Filopodia: molecular architecture and cellular functions

Rho and Rac take center stage

Guanine nucleotide exchange factors for Rho GTPases: turning on the switch

SGEF enhances EGFR stability through delayed EGFR trafficking from early to late endosomes.

SGEF is overexpressed in prostate cancer and contributes to prostate cancer progression.

Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.

A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.

P2888

s12957-018-1331-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12957-018-1331-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hong Zheng

P577

2018-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101085600

http://www.w3.org/2001/XMLSchema#string

P698

29454349

http://www.w3.org/2001/XMLSchema#string

P932

5816374

http://www.w3.org/2001/XMLSchema#string